Trump Reportedly Planning Board That Could Veto “Woke” NIH Research Funding

The Trump NIH funding board reportedly being developed by the administration would grant unprecedented political oversight over which biomedical research projects receive federal funding, representing another significant step in the administration’s ongoing effort to reshape scientific research priorities according to ideological criteria.

What The Executive Order Would Do

According to reporting from outlets including the Washington Post and Politico, Trump’s anticipated executive order would establish a new board specifically responsible for approving National Institutes of Health grant funding. The order emerged from discussions during a Friday meeting where senior administration officials accused the NIH of funding what they characterized as woke initiatives that conflicted with Trump’s political priorities.

Russell Vought, who directs the White House’s Office of Management and Budget, along with other administration officials, proposed creating an external committee empowered to veto biomedical research awards that don’t align with the administration’s goals, according to multiple sources who spoke with the Washington Post.

Politico reported that this board would include both Vought and NIH Director Jay Bhattacharya, with the requirement that decisions on grant awards reach unanimous agreement among board members before proceeding. As the White House agency responsible for implementing presidential policy throughout the executive branch, OMB’s involvement signals just how directly this initiative connects to broader administration priorities.

A Break From Traditional Scientific Review

This proposed arrangement represents a significant departure from how the NIH has traditionally evaluated research proposals, a process historically centered on scientific merit rather than political considerations. Bhattacharya has reportedly pushed back against cuts to federal research spending and defended the agency’s existing grant-making process during Friday’s meeting, even as Vought expressed clear interest in fundamentally reshaping how federal research dollars get allocated.

This tension between Bhattacharya’s defense of scientific evaluation standards and Vought’s push for greater political control suggests genuine disagreement exists within the administration itself about how far this restructuring should go.

Legal Challenges Already Underway

This reported move comes as the NIH, which stands as the world’s largest public funder of biomedical research, already faces a class-action lawsuit from researchers who argue the Trump administration has been hindering and terminating scientific grants specifically to suppress viewpoints that conflict with the president’s ideological positions. The lawsuit accuses the administration of violating First Amendment protections.

The legal complaint specifically argues that while the government maintains broad authority over its own funding decisions, the Constitution doesn’t permit using that funding power to target or silence disfavored viewpoints within the broader biomedical research community.

A Broader Pattern Of Research Funding Cuts

This development fits into a larger pattern that has emerged since Trump began his second term. Billions of dollars in federal grants covering health, nutrition, environmental research, and disaster relief programs have already been cut or frozen during this period. The administration has reportedly flagged research proposals containing specific keywords, including terms like equity, racist, gender, and climate change, as part of an effort to restrict funding for studies touching on these topics.

Neither the Department of Health and Human Services, which oversees NIH operations, nor the White House immediately responded to requests for comment regarding the reported executive order and its potential implications for the future of federally funded biomedical research in the United States.